The global demand for Pharmacovigilance and Drug Safety Software Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Pharmacovigilance and drug safety software is an application that reduces product safety risk, achieves compliance, and improves the efficiency of pharmacovigilance processes. It identifies the cause of withdrawal and helps to inhibit unnecessary future events. Software reports and manages safety and regulation, consistently track status reports to governments and clients, enable access to records, and medicine advancement expertise. The software is approved by regulating agencies, pharmaceutical companies, and medical professionals.
Automation and digitalization is an increasing trend in every sector, including clinical research. Growing research on new therapies and drugs is augmenting the growth of the market. Infectious life-threatening diseases have a massive effect in terms of mortality and morbidity and oblige substantial economic trouble on affected countries. Currently, available drugs are insufficient for the majority of these diseases, and there is an urgent need for new treatments. From a research start to close out, pharmacovigilance software plays a crucial role in clinical research. This software help reduce the administrative burdens and workloads by consolidating information in a familiar location, supports the trial round by facilitating the cooperation between all the researches. Incorporation of this software dramatically enhances the speed and efficiency in maintaining, planning, performing, managing, and reporting of the research or study data. Pharmacovigilance and Drug Safety Softwares are great tools in the clinical research domain to collect trial data to track study performance, schedule, monitor, and many more. Due to a massive bundle of advantages, it is predicted that more and more clinical research will use this software to grab the benefits that will eventually result in the healthy growth of the market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of Pharmacovigilance and Drug Safety Software.
The entire Pharmacovigilance and Drug Safety Software market has been sub-categorized into functionality, delivery mode, and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Delivery Mode
- Adverse Event Reporting Software
- Drug Safety Audits Software
- Issue Tracking Software
- Fully Integrated Software
- On-Premise Delivery Mode
- On-Demand/Cloud Based (Saas) Delivery Mode
- Pharma and Biotech Companies
- Contract Research Organizations (CROS)
- Business Process Outsourcing (BPO) Firms
- Other Pharmacovigilance Service Providers
This section covers regional segmentation which accentuates on current and future demand for Pharmacovigilance and Drug Safety Software market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Pharmacovigilance and Drug Safety Software Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pharmacovigilance and Drug Safety Software market include ArisGlobal, Ennov Solutions Inc., EXTEDO GmbH, Online Business Applications, Inc., Oracle Corporation. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.